ASH 2023: Sickle Cell Disease Education Programme
Sickle cell disease (SCD) affects over 400,000 newborns annually, with particularly high mortality rates in low- and middle-income countries (LMICs) such as India and Sub-Saharan Africa (SSA). At this year's American Society of Hematology conference in San Diego, MedShr founder Dr Asif Qasim presents a groundbreaking mobile-first medical education programme and its impact on SCD diagnosis and management in Kenya, Ghana, Zambia, Uganda, Tanzania and India.
